Maxigen Biotech Inc. (1783.TW)
TWD 42.05
(2.31%)
TWD 42.05
(2.31%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.49 Billion TWD | 3.13% |
| 2022 | 1.44 Billion TWD | 14.43% |
| 2021 | 1.26 Billion TWD | 32.28% |
| 2020 | 956.47 Million TWD | -19.32% |
| 2019 | 1.18 Billion TWD | 4.41% |
| 2018 | 1.13 Billion TWD | 2.85% |
| 2017 | 1.1 Billion TWD | 0.6% |
| 2016 | 1.09 Billion TWD | -6.06% |
| 2015 | 1.16 Billion TWD | 15.25% |
| 2014 | 1.01 Billion TWD | -0.08% |
| 2013 | 1.01 Billion TWD | 100.57% |
| 2012 | 505.76 Million TWD | 3.93% |
| 2011 | 486.65 Million TWD | 13.24% |
| 2010 | 429.75 Million TWD | 25.09% |
| 2009 | 343.54 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.56 Billion TWD | 5.2% |
| 2024 Q1 | 1.48 Billion TWD | -0.22% |
| 2023 Q3 | 1.54 Billion TWD | 2.04% |
| 2023 Q2 | 1.51 Billion TWD | 1.32% |
| 2023 FY | 1.49 Billion TWD | 3.13% |
| 2023 Q1 | 1.49 Billion TWD | 3.08% |
| 2023 Q4 | 1.49 Billion TWD | -3.23% |
| 2022 Q2 | 1.31 Billion TWD | 3.31% |
| 2022 Q1 | 1.27 Billion TWD | 0.74% |
| 2022 FY | 1.44 Billion TWD | 14.43% |
| 2022 Q4 | 1.44 Billion TWD | 5.11% |
| 2022 Q3 | 1.37 Billion TWD | 4.61% |
| 2021 Q3 | 1.24 Billion TWD | 22.16% |
| 2021 Q4 | 1.26 Billion TWD | 1.91% |
| 2021 Q1 | 977.36 Million TWD | 2.18% |
| 2021 FY | 1.26 Billion TWD | 32.28% |
| 2021 Q2 | 1.01 Billion TWD | 3.98% |
| 2020 Q4 | 956.47 Million TWD | 2.75% |
| 2020 FY | 956.47 Million TWD | -19.32% |
| 2020 Q1 | 969.27 Million TWD | -18.24% |
| 2020 Q2 | 975.96 Million TWD | 0.69% |
| 2020 Q3 | 930.84 Million TWD | -4.62% |
| 2019 Q1 | 1.15 Billion TWD | 1.67% |
| 2019 Q2 | 1.19 Billion TWD | 3.62% |
| 2019 Q3 | 1.15 Billion TWD | -3.39% |
| 2019 Q4 | 1.18 Billion TWD | 2.58% |
| 2019 FY | 1.18 Billion TWD | 4.41% |
| 2018 Q3 | 1.12 Billion TWD | -0.46% |
| 2018 Q1 | 1.09 Billion TWD | -0.76% |
| 2018 FY | 1.13 Billion TWD | 2.85% |
| 2018 Q4 | 1.13 Billion TWD | 1.26% |
| 2018 Q2 | 1.12 Billion TWD | 2.83% |
| 2017 Q4 | 1.1 Billion TWD | 1.21% |
| 2017 Q2 | 1.08 Billion TWD | 0.4% |
| 2017 Q1 | 1.07 Billion TWD | -1.77% |
| 2017 FY | 1.1 Billion TWD | 0.6% |
| 2017 Q3 | 1.09 Billion TWD | 0.79% |
| 2016 Q2 | 1.11 Billion TWD | -0.92% |
| 2016 Q1 | 1.12 Billion TWD | -3.53% |
| 2016 FY | 1.09 Billion TWD | -6.06% |
| 2016 Q4 | 1.09 Billion TWD | -0.23% |
| 2016 Q3 | 1.09 Billion TWD | -1.5% |
| 2015 Q3 | 978.21 Million TWD | -2.17% |
| 2015 FY | 1.16 Billion TWD | 15.25% |
| 2015 Q4 | 1.16 Billion TWD | 19.43% |
| 2015 Q2 | 999.86 Million TWD | 0.63% |
| 2015 Q1 | 993.65 Million TWD | -1.97% |
| 2014 Q1 | 1.02 Billion TWD | 1.07% |
| 2014 Q4 | 1.01 Billion TWD | -1.71% |
| 2014 FY | 1.01 Billion TWD | -0.08% |
| 2014 Q3 | 1.03 Billion TWD | 0.85% |
| 2014 Q2 | 1.02 Billion TWD | -0.26% |
| 2013 FY | 1.01 Billion TWD | 100.57% |
| 2013 Q2 | 731.33 Million TWD | 0.0% |
| 2013 Q3 | 736.3 Million TWD | 0.68% |
| 2013 Q4 | 1.01 Billion TWD | 37.77% |
| 2013 Q1 | - TWD | -100.0% |
| 2012 Q4 | 505.76 Million TWD | 0.0% |
| 2012 FY | 505.76 Million TWD | 3.93% |
| 2012 Q2 | 502.03 Million TWD | 0.0% |
| 2011 Q2 | 508.71 Million TWD | 0.0% |
| 2011 Q4 | 486.65 Million TWD | 0.0% |
| 2011 FY | 486.65 Million TWD | 13.24% |
| 2010 Q4 | 429.75 Million TWD | 0.0% |
| 2010 FY | 429.75 Million TWD | 25.09% |
| 2009 FY | 343.54 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Nang Kuang Pharmaceutical Co., Ltd. | 3.85 Billion TWD | 61.283% |
| SciVision Biotech Inc. | 2.16 Billion TWD | 30.886% |
| Bionime Corporation | 5.3 Billion TWD | 71.834% |
| Pegavision Corporation | 13.85 Billion TWD | 89.227% |
| Visco Vision Inc. | 4.72 Billion TWD | 68.395% |